Award
Purchase Order #75N98026P01001
Life Technologies Contract for Whole-Exome Sequencing Reagents
Buyer
National Institutes of Health
Award Amount
$109,676.46
Ceiling
$109,676.46
Awarded
August 07, 2026
Period of Performance
Aug 07, 2026 – Aug 06, 2027
Identifier
75N98026P01001
NAICS
325414
This contract is a purchase order awarded to Life Technologies Corporation, a company specializing in biotechnology and life sciences products. The contract involves procuring whole-exome enrichment and sequencing reagents, which are crucial for identifying uncommon and rare genetic variants linked to alcohol-related phenotypes in newly recruited patients. The significance of this contract lies in its support of advanced genomic research, aiding in the understanding of genetic factors in alcohol-related disorders, which is vital for medical research and public health initiatives. The scope covers the supply of specialized reagents necessary for whole-exome sequencing processes. Awarded through a competitive acquisition process, the contract has a defined one-year performance period, exemplifying a focused effort on this specific research need. The work will be performed in Carlsbad, California, reflecting the location of the recipient's operations.
Description
XOME ENRICHMENT AND SEQUENCING REGENTS ARE REQUIRED FOR WHOLE-EXOME SEQUENCING TO IDENTIFY UNCOMMON AND RARE SEQUENCE VARIANTS ACROSS ALL PROTEIN CODING SEQUENCES THAT CONTRIBUTE TO ALCOHOL-RELATED PHENOTYPES IN NEWLY RECRUITED PATIENTS WITH ALCOHOL